Western Pacific Wealth Management »

Crispr Therapeutics shares owned by Western Pacific Wealth Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Western Pacific Wealth Management from 13F filings

Historical chart of Western Pacific Wealth Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Western Pacific Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Western Pacific Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $24k 500 46.98

More positions owned by Western Pacific Wealth Management

Nike Inc Cl B Stock (NKE)
Apple Stock (AAPL)
Vanguard Dividend Appreciation Etf Etf (VIG)
Amazon Stock (AMZN)
Vanguard High Dividend Yield Index Etf Etf (VYM)
Microsoft Corp Stock (MSFT)
Nvidia Corporation Stock (NVDA)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Meta Platforms Inc Cl A Stock (META)
Palantir Technologies Inc Cl A Stock (PLTR)
Costco Whsl Corp Stock (COST)
Tesla Stock (TSLA)
Intuitive Surgical Stock (ISRG)

View all positions for Western Pacific Wealth Management

Top funds holding Crispr Therapeutics

Capital Research and Management Company - Division 3
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
BlackRock
T. Rowe Price Investment Management
State Street Corporation
Vanguard Group
NEA Management Company
Citadel Advisors
EcoR1 Capital
Susquehanna International
Bank of America Corporation
Sr One Capital Management

View all funds holding Crispr Therapeutics